Insider Trading Alert - RP, OHI And LH Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, June 6, 2014, 96 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,133.00 to $126,311,991.43.

Highlighted Stocks Traded by Insiders:

Realpage (RP) - FREE Research Report

Seren Capital, Ltd., who is 10% Owner at Realpage, sold 3,200 shares at $21.30 on June 6, 2014. Following this transaction, the 10% Owner owned 20.2 million shares meaning that the stake was reduced by 0.02% with the 3,200-share transaction.

The shares most recently traded at $21.66, up $0.36, or 1.69% since the insider transaction. Historical insider transactions for Realpage go as follows:

  • 4-Week # shares bought: 50,000
  • 4-Week # shares sold: 74,964
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 77,401
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 119,787

The average volume for Realpage has been 509,800 shares per day over the past 30 days. Realpage has a market cap of $1.7 billion and is part of the technology sector and computer software & services industry. Shares are down 6.93% year-to-date as of the close of trading on Friday.

RealPage, Inc. provides on demand software solutions for the rental housing industry in North America. The company has a P/E ratio of 85.7. Currently, there are 2 analysts who rate Realpage a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RP - FREE

TheStreet Quant Ratings rates Realpage as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full Realpage Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Omega Healthcare Investors (OHI) - FREE Research Report

Pickett C Taylor, who is Chief Executive Officer at Omega Healthcare Investors, sold 30,000 shares at $38.06 on June 6, 2014. Following this transaction, the Chief Executive Officer owned 242,849 shares meaning that the stake was reduced by 11% with the 30,000-share transaction.

Crabill R Lee, who is Senior Vice President at Omega Healthcare Investors, sold 10,000 shares at $38.02 on June 6, 2014. Following this transaction, the Senior Vice President owned 59,056 shares meaning that the stake was reduced by 14.48% with the 10,000-share transaction.

Stephenson Robert O, who is Chief Financial Officer at Omega Healthcare Investors, sold 12,500 shares at $37.95 on June 6, 2014. Following this transaction, the Chief Financial Officer owned 142,471 shares meaning that the stake was reduced by 8.07% with the 12,500-share transaction.

Booth Daniel J, who is Chief Operating Officer at Omega Healthcare Investors, sold 20,000 shares at $37.93 on June 6, 2014. Following this transaction, the Chief Operating Officer owned 167,263 shares meaning that the stake was reduced by 10.68% with the 20,000-share transaction.

Ritz Michael, who is Chief Accounting Officer at Omega Healthcare Investors, sold 2,500 shares at $38.00 on June 6, 2014. Following this transaction, the Chief Accounting Officer owned 2,722 shares meaning that the stake was reduced by 47.87% with the 2,500-share transaction.

The shares most recently traded at $37.86, down $0.14, or 0.37% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 4-Week # shares bought: 32,424
  • 4-Week # shares sold: 52,500
  • 12-Week # shares bought: 32,424
  • 12-Week # shares sold: 77,500
  • 24-Week # shares bought: 32,424
  • 24-Week # shares sold: 77,500

The average volume for Omega Healthcare Investors has been 1.0 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.8 billion and is part of the financial sector and real estate industry. Shares are up 26.98% year-to-date as of the close of trading on Friday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.25%. The company has a P/E ratio of 24.3. Currently, there is 1 analyst who rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Laboratory Corp of America Hldgs (LH) - FREE Research Report

Brecher Mark E, who is Chief Medical Officer at Laboratory Corp of America Hldgs, sold 2,600 shares at $102.31 on June 6, 2014. Following this transaction, the Chief Medical Officer owned 5,754 shares meaning that the stake was reduced by 31.12% with the 2,600-share transaction.

The shares most recently traded at $103.59, up $1.28, or 1.24% since the insider transaction. Historical insider transactions for Laboratory Corp of America Hldgs go as follows:

  • 4-Week # shares sold: 2,497
  • 12-Week # shares sold: 2,497
  • 24-Week # shares sold: 9,965

The average volume for Laboratory Corp of America Hldgs has been 1.1 million shares per day over the past 30 days. Laboratory Corp of America Hldgs has a market cap of $8.9 billion and is part of the health care sector and health services industry. Shares are up 13.21% year-to-date as of the close of trading on Friday.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company has a P/E ratio of 17.4. Currently, there are 6 analysts who rate Laboratory Corp of America Hldgs a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LH - FREE

TheStreet Quant Ratings rates Laboratory Corp of America Hldgs as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corp of America Hldgs Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

"Strong Case for More Rate Hikes" Says Fed Chair Jerome Powell

"Strong Case for More Rate Hikes" Says Fed Chair Jerome Powell

Disney Tops Comcast Bid With Improved $71.3 Billion Approach for Fox

Disney Tops Comcast Bid With Improved $71.3 Billion Approach for Fox

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

European Union Says Tariffs on U.S. Imports Will Kick In on June 22